Queen's University Belfast-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2023

  1. Corrigendum to “Development of intranasal implantable devices for schizophrenia treatment” [Int. J. Pharm. 624 (2021) 122061] (International Journal of Pharmaceutics (2022) 624, (S0378517322006159), (10.1016/j.ijpharm.2022.122061))

    International Journal of Pharmaceutics

  2. Radiolabeled Risperidone microSPECT/CT Imaging for Intranasal Implant Studies Development

    Pharmaceutics, Vol. 15, Núm. 3

2022

  1. Development of intranasal implantable devices for schizophrenia treatment

    International Journal of Pharmaceutics, Vol. 624

2019

  1. Dissolving microneedles for intradermal vaccination against shigellosis

    Vaccines, Vol. 7, Núm. 4